More than a decade after Theranos collapsed, diagnostics companies are pursuing its vision and questioning whether the lab ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

A high-throughput drug screening platform uses DNA nanoswitches to identify compounds capable of changing how proteins ...

Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy ...

The human pangenome improved somatic mutation detection, revealing thousands of candidate mutations in a melanoma cell line.

An Australian study suggests a supervised food challenge may be the best way to diagnose peanut allergy in young children.

Dyve Biosciences targets acidic microenvironments in cancer and inflammatory conditions through transdermal delivery.

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...